Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 29 January 2025.
-
New precision therapy for bile duct cancer extends patients’ lives
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
This page offers advice to patients who are feeling sick.
-
Bed availability is a “significant” factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time.
File results
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0541 - Healthcare-associated infections (HAIs) 2022-2024
-
FOI/2024/0542 - Single-use medical items usage at Trust
-
FOI/2024/0210 - Clear identification of registered nurses/ job title on badges
-
FOI/2024/0554 - Robotic Process Automation (RPA) Programme
-
FOI/2024/0475 - Prophylactic hydrocortisone neonatal deaths in 2023
-
FOI/2024/0091 - Primary HIFU PA procedures/ salvage HIFU procedures HEAT registry
-
FOI/2024/0548 - Patient transport services, providers/ charges
-
FOI/2024/0550 - Syntometrine vs Misoprostol/ treatment uses for post-partum haemorrhage
-
FOI/2024/0559 - Surgical Robots purchase/ simulators/ procedures 2019-2024